Qualitek Labs Ltd
Founded in 2018, Qualitek Labs Limited provides testing, inspection, homologation, certification, and consulting services.[1]
- Market Cap ₹ 465 Cr.
- Current Price ₹ 399
- High / Low ₹ 459 / 215
- Stock P/E 73.0
- Book Value ₹ 121
- Dividend Yield 0.00 %
- ROCE 10.8 %
- ROE 8.93 %
- Face Value ₹ 10.0
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Services Services Commercial Services & Supplies Consulting Services
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|
| 6.35 | 11.96 | 19.14 | 29.18 | 45.86 | 53.94 | |
| 5.32 | 9.65 | 13.84 | 21.11 | 34.14 | 40.17 | |
| Operating Profit | 1.03 | 2.31 | 5.30 | 8.07 | 11.72 | 13.77 |
| OPM % | 16.22% | 19.31% | 27.69% | 27.66% | 25.56% | 25.53% |
| 0.02 | 0.05 | 0.18 | 0.08 | 0.15 | 0.14 | |
| Interest | 0.01 | 0.32 | 0.70 | 0.93 | 1.49 | 1.73 |
| Depreciation | 0.35 | 0.50 | 0.84 | 1.40 | 3.27 | 3.80 |
| Profit before tax | 0.69 | 1.54 | 3.94 | 5.82 | 7.11 | 8.38 |
| Tax % | 33.33% | 26.62% | 25.13% | 26.12% | 25.60% | |
| 0.46 | 1.14 | 2.94 | 4.31 | 5.28 | 6.37 | |
| EPS in Rs | 460.00 | 24.78 | 5.44 | 5.85 | 5.29 | 5.98 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 57% |
| TTM: | 43% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 67% |
| TTM: | 59% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 44% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 15% |
| Last Year: | 9% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.46 | 5.41 | 7.37 | 9.98 | 11.65 |
| Reserves | -0.24 | 1.44 | 4.49 | 25.08 | 75.81 | 128.93 |
| 11.22 | 17.29 | 23.45 | 12.25 | 28.51 | 47.32 | |
| 3.61 | 3.01 | 6.24 | 5.89 | 8.39 | 8.96 | |
| Total Liabilities | 14.60 | 22.20 | 39.59 | 50.59 | 122.69 | 196.86 |
| 6.33 | 7.57 | 13.67 | 29.51 | 40.65 | 47.76 | |
| CWIP | 4.47 | 4.47 | 14.85 | 7.61 | 13.38 | 19.10 |
| Investments | 0.01 | 0.01 | 0.00 | 0.00 | 37.99 | 89.99 |
| 3.79 | 10.15 | 11.07 | 13.47 | 30.67 | 40.01 | |
| Total Assets | 14.60 | 22.20 | 39.59 | 50.59 | 122.69 | 196.86 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 1.35 | -5.12 | 7.22 | 5.54 | 8.01 | |
| -6.07 | -1.73 | -17.41 | -11.61 | -67.49 | |
| 4.82 | 6.74 | 10.51 | 6.14 | 60.77 | |
| Net Cash Flow | 0.10 | -0.11 | 0.33 | 0.06 | 1.29 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Debtor Days | 68.98 | 66.84 | 111.18 | 98.19 | 93.84 |
| Inventory Days | |||||
| Days Payable | |||||
| Cash Conversion Cycle | 68.98 | 66.84 | 111.18 | 98.19 | 93.84 |
| Working Capital Days | -683.44 | -399.49 | -199.28 | 38.28 | -19.50 |
| ROCE % | 12.33% | 17.78% | 17.30% | 10.82% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
3h - H1 FY26 consolidated revenue ₹54.2Cr (+37% YoY); PAT ₹4.8Cr; completed 100% acquisition of ITCPL.
- Results - Financial Results For September 30, 2025 (Unaudited) 1d
-
Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, November 12, 2025, Pursuant To Regulation 30 And 33 Of The SEBI (LODR) Regulations, 2015.
1d - H1 results: Consolidated revenue ₹5,132.90L, net profit ₹476.94L; acquired subsidiaries; slump sale ₹8.8Cr.
-
Board Meeting Intimation for Board Meeting Intimation For Approval Of Unaudited Financial Results
3 Nov - Board meeting Nov 12, 2025 to approve unaudited results for quarter/half-year ended Sep 30, 2025; trading window closed.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
9 Oct - Certificate received from RTA Skyline Financial Service Private Limited Confirming Compliance for Quarter and Half Year Ended September 30 2025
Annual reports
Concalls
-
May 2025TranscriptNotesPPT
Business Profile[1] Qualitek Labs Ltd. (QLL) provides testing, inspection, homologation, certification, and consultancy services to various industries viz automotive, defense, metals & metallurgy, environment and water, minerals, food & agriculture, pharma & healthcare.